Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandra Drakaki

Showing results (21-30 of 133) with videos related to

Pageof 14
Sort By:
International Journal of Oncology|January 17, 2009
Epigenetic regulation of hTERT promoter in hepatocellular carcinomasDimitrios Iliopoulos, Maria Satra, Alexandra Drakaki, et al.
Case Reports in Oncological Medicine|April 26, 2019
Treating Penile Cancer in the Immunotherapy and Targeted Therapy EraGavin Hui, Sanaz N Ghafouri, John Shen, et al.
International Journal of Molecular Sciences|September 14, 2024
MicroRNAs in Genitourinary Malignancies: An Exciting Frontier of Cancer Diagnostics and TherapeuticsNikhita Kathuria-Prakash, Pranali Dave, Lizette Garcia, et al.
Trends in Immunology|February 28, 2026
Cytokine specificity in macrophages: JAK-STAT and beyondJosje M A Huisman, Alexandra Drakaki, Thomas Decker, et al.
Clinical Genitourinary Cancer|February 9, 2021
The Evolving Landscape of Antibody-Drug Conjugates for Urothelial CarcinomaMelissa Abel, Aaron Burkenroad, Alexander Sun, et al.
Cancer Causes & Control : CCC|March 23, 2019
Second primary lung cancer in United States Cancer Survivors, 1992-2008Nicholas M Donin, Lorna Kwan, Andrew T Lenis, et al.
Case Reports in Oncology|July 13, 2016
Human Epidermal Growth Factor Receptor 2 (HER-2/neu)-Directed Therapy for Rare Metastatic Epithelial Tumors with HER-2 AmplificationDaniel Sanghoon Shin, Timothy Sherry, Michael E Kallen, et al.
World Journal of Urology|June 3, 2018
Epidemiology, biology and treatment of sarcomatoid RCC: current state of the artCedric Lebacle, Aydin Pooli, Thomas Bessede, et al.
Current Cancer Reports|October 14, 2024
Risk of severe immune-related adverse events in cancer patients with pre-existing autoimmunity receiving immune checkpoint inhibitor therapyDayna Jill Isaacs, Nikhita Kathuria-Prakash, Robin Hilder, et al.
Cureus|June 20, 2025
A Rare Presentation of Priapism From Pegylated Filgrastim During Treatment of Urothelial Cancer in an African-American Patient With Sickle Cell TraitNikhita Kathuria-Prakash, Leland Damron, Sandy C Hernandez, et al.
Pageof 14

Showing results (21-30 of 133) with videos related to

Sort By:
Pageof 14
International Journal of Oncology|January 17, 2009
Epigenetic regulation of hTERT promoter in hepatocellular carcinomasDimitrios Iliopoulos, Maria Satra, Alexandra Drakaki, et al.
Case Reports in Oncological Medicine|April 26, 2019
Treating Penile Cancer in the Immunotherapy and Targeted Therapy EraGavin Hui, Sanaz N Ghafouri, John Shen, et al.
International Journal of Molecular Sciences|September 14, 2024
MicroRNAs in Genitourinary Malignancies: An Exciting Frontier of Cancer Diagnostics and TherapeuticsNikhita Kathuria-Prakash, Pranali Dave, Lizette Garcia, et al.
Trends in Immunology|February 28, 2026
Cytokine specificity in macrophages: JAK-STAT and beyondJosje M A Huisman, Alexandra Drakaki, Thomas Decker, et al.
Clinical Genitourinary Cancer|February 9, 2021
The Evolving Landscape of Antibody-Drug Conjugates for Urothelial CarcinomaMelissa Abel, Aaron Burkenroad, Alexander Sun, et al.
Cancer Causes & Control : CCC|March 23, 2019
Second primary lung cancer in United States Cancer Survivors, 1992-2008Nicholas M Donin, Lorna Kwan, Andrew T Lenis, et al.
Case Reports in Oncology|July 13, 2016
Human Epidermal Growth Factor Receptor 2 (HER-2/neu)-Directed Therapy for Rare Metastatic Epithelial Tumors with HER-2 AmplificationDaniel Sanghoon Shin, Timothy Sherry, Michael E Kallen, et al.
World Journal of Urology|June 3, 2018
Epidemiology, biology and treatment of sarcomatoid RCC: current state of the artCedric Lebacle, Aydin Pooli, Thomas Bessede, et al.
Current Cancer Reports|October 14, 2024
Risk of severe immune-related adverse events in cancer patients with pre-existing autoimmunity receiving immune checkpoint inhibitor therapyDayna Jill Isaacs, Nikhita Kathuria-Prakash, Robin Hilder, et al.
Cureus|June 20, 2025
A Rare Presentation of Priapism From Pegylated Filgrastim During Treatment of Urothelial Cancer in an African-American Patient With Sickle Cell TraitNikhita Kathuria-Prakash, Leland Damron, Sandy C Hernandez, et al.
Pageof 14